(Q79390842)
Statements
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab (English)
Klaus Bendtzen
Pierre Geborek
Morten Svenson
Lotta Larsson
1 December 2006